GP73 and AFP of HCC with different tumour sizes, differentiations and liver functions
| Tumour size (cm) | ≤3 (n=45) | >3 and <5 (n=126) | ≥5 (n=197) | Diffuse (n=55) | |||
| GP73 value (RU) | 16.1 (10.6–42.6) | 14.1 (6.8–42.6) | 18.6 (12.3–38.8) | 17.6 (8.3–35.1) | |||
| AFP (ng/ml) | 29.8 (10.1–34.9)* | 102.7 (11.2–360.4) | 129.6 (10.8–353.2) | 121.8 (11.0–358.7) | |||
| Tumour differentiation | High (n=52) | Moderate (n=80) | Low (n=48) | ||||
| GP73 value (RU) | 12.9 (7.4–46.2) | 19.0 (8.3–39.3) | 17.6 (9.9–65.2) | ||||
| AFP (ng/ml) | 119.0 (20.8–478.6) | 129.8 (18.9–442.5) | 143.1 (12.9–465.3) | ||||
| Child–Pugh class | A (n=221) | B (n=162) | C (n=43) | ||||
| GP73 value (RU) | 15.6 (10.2–38.9) | 14.6 (9.4–41.2) | 16.8 (11.0–52.6) | ||||
| AFP (ng/ml) | 108.9 (14.0–395.6) | 122.6 (24.8–410.2) | 124.6 (22.1–469.3) | ||||
↵* p<0.001 vs >3 and <5, ≥5 and diffuse HCC.
AFP, alpha-fetoprotein; GP73, Golgi protein 73; HCC, hepatocellular carcinoma; RU, relative units.